Company news
Supha Pharmachem Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Supha Pharmachem Ltd Press Release Jun 27 2026
June 27, 2026
Closure of Trading Window
June 27, 2026
Supha Pharmachem Ltd Press Release Apr 17 2026
April 17, 2026
Post- Coc Update
April 17, 2026
Supha Pharmachem Ltd Press Release Apr 10 2026
April 10, 2026
Corporate Insolvency Resolution Process (CIRP)-List of Creditors
April 10, 2026
Supha Pharmachem Ltd Press Release Apr 02 2026
April 2, 2026
Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
April 2, 2026
Supha Pharmachem Ltd Press Release Mar 25 2026
March 25, 2026
Closure of Trading Window
March 25, 2026
Supha Pharmachem Ltd Press Release Mar 21 2026
March 21, 2026
Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)
March 21, 2026
Supha Pharmachem Ltd Press Release Mar 17 2026
March 17, 2026
Intimation Of Change In Registered Office
March 17, 2026
Supha Pharmachem Ltd Press Release Feb 17 2026
February 17, 2026
Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026
February 17, 2026
Supha Pharmachem Ltd Press Release Feb 03 2026
February 3, 2026
Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
February 3, 2026
Supha Pharmachem Ltd Press Release Jan 20 2026
January 19, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
January 19, 2026
Supha Pharmachem Ltd Press Release Dec 22 2025
December 22, 2025
Closure of Trading Window
December 22, 2025
Supha Pharmachem Ltd Press Release Dec 15 2025
December 15, 2025
Announcement under Regulation 30 (LODR)-Change of Company Name
December 15, 2025
Supha Pharmachem Ltd Press Release Dec 08 2025
December 8, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
December 8, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
December 8, 2025
Supha Pharmachem Ltd Press Release Nov 17 2025
November 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
November 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
November 16, 2025
Supha Pharmachem Ltd Press Release Nov 14 2025
November 14, 2025
Results - Financial Results For Quarter And Half Year Ended September 30, 2025
November 14, 2025
Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2025
November 14, 2025
Supha Pharmachem Ltd Press Release Nov 10 2025
November 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
November 10, 2025
Supha Pharmachem Ltd Press Release Nov 06 2025
November 5, 2025
Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025
November 5, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
November 5, 2025
Supha Pharmachem Ltd Press Release Nov 04 2025
November 4, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
November 4, 2025
Supha Pharmachem Ltd Press Release Oct 31 2025
October 31, 2025
Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman Gawde
October 31, 2025
Board Meeting Outcome for Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulation, 2015 For Outcome Of Board Meeting Held On Friday, 31St October, 2025
October 31, 2025
Supha Pharmachem Ltd Press Release Oct 29 2025
October 29, 2025
Announcement under Regulation 30 (LODR)-Resignation of Director
October 29, 2025
Supha Pharmachem Ltd Press Release Oct 10 2025
October 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
October 10, 2025
Supha Pharmachem Ltd Press Release Oct 06 2025
October 6, 2025
Announcement under Regulation 30 (LODR)-Resignation of Director
October 6, 2025
Supha Pharmachem Ltd Press Release Sep 24 2025
September 24, 2025